Effects of repeated endotoxin injections on prostanoids, hemodynamics, endothelial cells, and survival in ponies.

The study aimed to investigate the effects of increasing doses of endotoxin on prostanoids, hemodynamics, endothelial cells, and survival in ponies. It also explored the protective influence of flunixin meglumine (FM), an anti-inflammatory drug, against these effects.

Research Design and Methodology

• The research involved eight ponies, which were divided into two groups. One group only received endotoxin injections, while the second was treated with endotoxin and flunixin.
• The scientists administered endotoxin intraperitoneally (within the peritoneal cavity) for 24 hours, after which they gave an intravenous endotoxin injection. At the same time, they monitored the ponies’ hemodynamic alterations and changes in serum prostanoid levels.
• The researchers also conducted a parallel study to investigate the survival time of two separate groups of eight ponies each, following the same endotoxin and treatment protocol.

Findings and Conclusion

• Both groups responded similarly until the delivery of the intravenous endotoxin injection after 24 hours. At this point, the protective power of flunixin became evident, as it prevented increases in prostacyclin and thromboxane concentrations while maintaining the cardiac output, systemic arterial blood pressure, and critical organ blood flow.
• Microscopic examination of the pulmonary arteries from the untreated ponies revealed extensive endothelial cell damage, whereas the group treated with FM showed reduced damage.
• In the survival study, two out of eight untreated ponies survived after seven days, compared to six out of eight in the treated group. This indicates that flunixin can significantly improve survival rates amongst ponies subjected to endotoxin administration.
• The results suggest that flunixin meglumine can effectively prevent the release of prostanoids, stabilize hemodynamics and blood flow, reduce vascular endothelial cell damage, and enhance survival.

In conclusion, this study provides valuable insight into the potential of flunixin meglumine as a protective treatment against the pathophysiological effects of repeated endotoxin administration in ponies.